article thumbnail

GSK and Wave Life Sciences partner to develop oligonucleotide therapeutics

Pharmaceutical Technology

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.

article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Dr Loubna Bouarfa, Founder and CEO, OKRA.ai

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IWD: Spotlight on women in life sciences

pharmaphorum

How did you get into life sciences? Dr Doina Ionescu (DI): After completing my PhD in physics at the University of Southampton, I joined Merck as a research scientist in 1998. DI: Transitioning from being a research scientist to a mergers & acquisitions project manager was not easy. What has your career path been?

article thumbnail

Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy – Xtalks Life Science Podcast Ep. 136

XTalks

This episode features an interview with Dr. Lahar Mehta, Head of Global Clinical Development at Amylyx Pharmaceuticals, who spoke to Xtalks about Amylyx’s clinical trial design of ORION, a Phase III Global Study of AMX0035 (Relyvrio) in Progressive Supranuclear Palsy (PSP).

article thumbnail

Parkinson’s Disease: Link With Melanoma + Drug Development – Xtalks Life Science Podcast Ep. 6

XTalks

FDA-mandated clinical holds, strategic partnership breakups and $800 million biotech acquisitions. She shares how well the firms have weathered the COVID-19 pandemic, and the team discusses the outlook for the drug development industry in general. Parkinson’s and Melanoma Share an Amyloid Link, Says New Research.

article thumbnail

Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck – Xtalks Life Science Podcast Ep. 140

XTalks

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

article thumbnail

4 Life Science Trends To Pay Attention To in 2021

XTalks

In other research areas, innovations in the pharmaceutical, medical device and biotech industries will benefit from approaches such as artificial intelligence (AI) and increased digitization. The burden of clinical trials is on all patient groups and patient segments. 1. COVID-19 Pandemic: An Evolving Era. AI and Neuroscience.